Erythropoietin or Darbepoetin for patients with cancer ‐ meta‐analysis based on individual patient data Edited (no change to conclusions)
Erythropoietin or Darbepoetin for patients with cancer ‐ meta‐analysis based on individual patient data Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Erythropoietin or Darbepoetin for Patients With Cancer ‐ Meta‐analysis Based On Individual Patient Data Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432933/1/Erythropoietin_or_Darbepoetin_for_patients_with_cancer_‐_meta‐analysis_based_on_individual_patient_data_Edited__no_change_to_conclusions_. Accessed 06 February 2023.
Erythropoietin or Darbepoetin for patients with cancer ‐ meta‐analysis based on individual patient data Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432933/1/Erythropoietin_or_Darbepoetin_for_patients_with_cancer_‐_meta‐analysis_based_on_individual_patient_data_Edited__no_change_to_conclusions_. Accessed February 6, 2023.
Erythropoietin or Darbepoetin for patients with cancer ‐ meta‐analysis based on individual patient data Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432933/1/Erythropoietin_or_Darbepoetin_for_patients_with_cancer_‐_meta‐analysis_based_on_individual_patient_data_Edited__no_change_to_conclusions_
Erythropoietin or Darbepoetin for Patients With Cancer ‐ Meta‐analysis Based On Individual Patient Data Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 February 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432933/1/Erythropoietin_or_Darbepoetin_for_patients_with_cancer_‐_meta‐analysis_based_on_individual_patient_data_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Erythropoietin or Darbepoetin for patients with cancer ‐ meta‐analysis based on individual patient data Edited (no change to conclusions)
ID - 432933
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432933/1/Erythropoietin_or_Darbepoetin_for_patients_with_cancer_‐_meta‐analysis_based_on_individual_patient_data_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -